Construction of a surrogate variable for impotence in the Massachusetts Male Aging Study
- PMID: 7730871
- DOI: 10.1016/0895-4356(94)90292-5
Construction of a surrogate variable for impotence in the Massachusetts Male Aging Study
Abstract
Uncollected data must be filled in after the fact in many epidemiological studies. We compared several methods for constructing a surrogate variable for erectile potency, based on responses to related questions, in the Massachusetts Male Aging Study (MMAS). Quadratic discriminant analysis performed best among the procedures tested, achieving high rates of correct classification in cross-validation of training data and (according to posterior estimates) in classification of MMAS subjects. Two versions of the surrogate variable were constructed, one involving a discrete classification and the other involving a set of continuous probabilities. The two versions were used to investigate medical correlates of impotence in MMAS and produced similar results, although the continuous version appeared to provide higher statistical power. We conclude that construction of a surrogate variable is a viable and potentially beneficial option in epidemiological investigations.
Similar articles
-
A new surrogate variable for erectile dysfunction status in the Massachusetts male aging study.J Clin Epidemiol. 2000 Jan;53(1):71-8. doi: 10.1016/s0895-4356(99)00150-x. J Clin Epidemiol. 2000. PMID: 10693906
-
Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study.J Urol. 1994 Jan;151(1):54-61. doi: 10.1016/s0022-5347(17)34871-1. J Urol. 1994. PMID: 8254833
-
Measurement of erectile dysfunction in population-based studies: the use of a single question self-assessment in the Massachusetts Male Aging Study.Int J Impot Res. 2000 Aug;12(4):197-204. doi: 10.1038/sj.ijir.3900542. Int J Impot Res. 2000. PMID: 11079360
-
[Epidemiology and age-related risk factors of erectile dysfunction].Wien Med Wochenschr. 2000;150(1-2):2-3. Wien Med Wochenschr. 2000. PMID: 10746286 Review. German.
-
Epidemiology of erectile dysfunction.Endocrine. 2004 Mar-Apr;23(2-3):87-91. doi: 10.1385/ENDO:23:2-3:087. Endocrine. 2004. PMID: 15146084 Review.
Cited by
-
Erectile dysfunction in chronic kidney disease: From pathophysiology to management.World J Nephrol. 2015 Jul 6;4(3):379-87. doi: 10.5527/wjn.v4.i3.379. World J Nephrol. 2015. PMID: 26167462 Free PMC article. Review.
-
Increased cavernosal relaxation by Phoneutria nigriventer toxin, PnTx2-6, via activation at NO/cGMP signaling.Int J Impot Res. 2012 Mar-Apr;24(2):69-76. doi: 10.1038/ijir.2011.47. Epub 2011 Oct 6. Int J Impot Res. 2012. PMID: 21975567 Free PMC article.
-
Safety and feasibility of platelet rich fibrin matrix injections for treatment of common urologic conditions.Investig Clin Urol. 2018 Jan;59(1):61-65. doi: 10.4111/icu.2018.59.1.61. Epub 2017 Dec 21. Investig Clin Urol. 2018. PMID: 29333517 Free PMC article.
-
Prevalence and determinants of erectile dysfunction in Santos, southeastern Brazil.Sao Paulo Med J. 2002 Mar 7;120(2):49-54. doi: 10.1590/s1516-31802002000200005. Sao Paulo Med J. 2002. PMID: 11994773 Free PMC article.
-
Sexual dysfunction and symptom impact in men with long-standing type 1 diabetes in the DCCT/EDIC cohort.J Sex Med. 2009 Jul;6(7):1969-78. doi: 10.1111/j.1743-6109.2009.01292.x. Epub 2009 Apr 28. J Sex Med. 2009. PMID: 19453899 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical